Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ACETAMINOPHEN AND CODEINE PHOSPHATE

ACETAMINOPHEN; CODEINE PHOSPHATE

Standard Dose
650MG;30MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ACETAMINOPHEN AND CODEINE PHOSPHATE is listed in Drugs@FDA under application 089231 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength TABLET;ORAL - 650MG;30MG Sponsor MIKART Submission history Latest submission status date: 2002-08-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview ACETAMINOPHEN AND CODEINE PHOSPHATE is listed in Drugs@FDA under application 089231 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength TABLET;ORAL - 650MG;30MG Sponsor MIKART Submission history Latest submission status date: 2002-08-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
ACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN; CODEINE PHOSPHATE) | Drug Monograph | MedicHelpline